Clinical trial
Safety and Effectiveness of Cardiac Resynchronization Therapy With…
NCT00387803 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00387803 |
|---|---|
| Title | Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation |
| Official title | VENTAK CHF/CONTAK CD Biventricular Pacing Study |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive, Ventricular Fibrillation, Tachycardia, Ventricular |
| Intervention type | Device |
| Interventions | Cardiac Resynchronization Therapy with Defibrillation |
| Enrollment | 581 |
| Start date | Feb 1, 1998 |
| Completion | Aug 1, 2001 |
| First posted | Oct 13, 2006 |
| Last update posted | Jan 25, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: